SkinBioTherapeutics (GB:SBTX) has released an update.
SkinBioTherapeutics, a life science company, has issued 2,349,624 new ordinary shares, boosting its total to 228,435,909 shares, as it prepares for trading on the AIM Market of the London Stock Exchange. This move reflects the company’s ongoing efforts to expand its investment base and strengthen its position in the skin health sector.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
